Cargando…
Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary Hypoadrenocorticism
BACKGROUND: Clinicians alter dosing for desoxycorticosterone pivalate (DOCP) to mitigate costs, but this practice has not been critically evaluated in a prospective clinical trial. HYPOTHESIS/OBJECTIVES: The duration of action of DOCP is longer than 30 days in dogs with primary hypoadrenocorticism (...
Autores principales: | Jaffey, J.A., Nurre, P., Cannon, A.B., DeClue, A.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697171/ https://www.ncbi.nlm.nih.gov/pubmed/28892205 http://dx.doi.org/10.1111/jvim.14828 |
Ejemplares similares
-
Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial
por: Vincent, Alysha M., et al.
Publicado: (2021) -
Evaluation of a low‐dose desoxycorticosterone pivalate treatment protocol for long‐term management of dogs with primary hypoadrenocorticism
por: Sieber‐Ruckstuhl, Nadia S., et al.
Publicado: (2019) -
Clinical features and long‐term management of cats with primary hypoadrenocorticism using desoxycorticosterone pivalate and prednisolone
por: Sieber‐Ruckstuhl, Nadja S., et al.
Publicado: (2023) -
Gallbladder Mucocele: Variables Associated with Outcome and the Utility of Ultrasonography to Identify Gallbladder Rupture in 219 Dogs (2007–2016)
por: Jaffey, J.A., et al.
Publicado: (2017) -
Evaluation of the Cortisol‐to‐ACTH Ratio in Dogs with Hypoadrenocorticism, Dogs with Diseases Mimicking Hypoadrenocorticism and in Healthy Dogs
por: Boretti, F.S., et al.
Publicado: (2015)